Print Create a hardcopy of this page Font Size: Default font size Larger font size National Public Health Week now under way Observation recognizes strides made, changes needed in US health system Posted: Monday, April 7, 2014 11:07 am Ertel Medicine now offering genetic testing Ertel Medicine and Pediatrics is now offering special genetic testing called pharmocogenetic testing. The test helps the medical provideradminister the most accurate treatment based on each patients unique science. Since everyone processes medications differently, this may be the key to help my patientsget to the sweet spot sooner, Dr.
UC Davis School of Veterinary Medicine researchers have identified the genetic mutation responsible for a form of cleft palate in the dog breed Nova Scotia Duck Tolling Retrievers. They hope that the discovery, which provides the first dog model for the craniofacial defect, will lead to a better understanding of cleft palate in humans
Irvine, CA (PRWEB) April 07, 2014 Proove Biosciences, the leader in Personalized Pain Medicine testing services, exhibited and presented research from three studies at the American Society of Interventional Pain Physicians’ (ASIPP) 16th annual meeting in New Orleans.
Some patients with a suspected genetic disorder will go on what medical professionals call a diagnostic odyssey to find the cause of their symptoms. A sample is run through the HiSeq 2000, a high-throughput sequencing system in the DNA lab at the University of Iowa Eckstein Medical Research Building in Iowa City. The green dots on the screen show a cluster of the fragment being sequenced.
New insights on the genetic drivers behind a rare type of fatal pediatric brain cancer may lead to the development of new patient-targeted treatments, a new study suggests. Each year about 30 children in Canada are diagnosed with diffuse intrinsic pontine glioma (DIPG), a pediatric cancer for which there is no effective treatment.
April 5, 2014, 3 a.m. A genetic test to predict the start of menopause is likely to be available within five years, allowing women to make more informed decisions about their health and fertility, a leading expert says. A genetic test to predict the start of menopause is likely to be available within five years, allowing women to make more informed decisions about their health and fertility, a leading expert says.
PUBLIC RELEASE DATE: 4-Apr-2014 Contact: Allison Hydzik email@example.com 412-559-2431 University of Pittsburgh Schools of the Health Sciences SAN DIEGO, April 4, 2014 An examination of the genetic landscape of head and neck cancers indicates that while metastatic and primary tumor cells share similar mutations, recurrent disease is associated with gene alterations that could be exquisitely sensitive to an existing cancer drug. Researchers from the University of Pittsburgh Cancer Institute (UPCI) and Yale University School of Medicine will share their findings during a mini-symposium Sunday at the American Association for Cancer Research Annual Meeting 2014. About 50 percent of patients diagnosed with head and neck squamous cell cancers already have disease that has spread, or metastasized, to the lymph nodes, explained Jennifer Grandis, M.D., distinguished professor and vice chair of research, Department of Otolaryngology, Pitt School of Medicine, and director of the Head and Neck Program at UPCI, partner with UPMC CancerCenter
April 4, 2014 This puppy is a Nova Scotia Duck Tolling Retriever, the breed with the newly discovered genetic mutation for cleft palate. (Danika Bannasch/UC Davis) UC Davis School of Veterinary Medicine researchers have identified the genetic mutation responsible for a form of cleft palate in the dog breed Nova Scotia Duck Tolling Retrievers.
PUBLIC RELEASE DATE: 4-Apr-2014 Contact: Allison Hydzik firstname.lastname@example.org 412-559-2431 University of Pittsburgh Schools of the Health Sciences SAN DIEGO, April 4, 2014 Genetic screening of cancer can help doctors customize treatments so that patients with melanoma have the best chance of beating it, according to the results of a clinical trial by researchers at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter. The trial, funded by the National Institutes of Health (NIH), will be presented Monday at the American Association for Cancer Research (AACR) Annual Meeting 2014. It showed that the cancer immune therapy drug ipilimumab appears most likely to prevent recurrence in patients whose cancer shows high expression of immune-related genes.
Transgenomic, Inc. , a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced an agreement with Raptor Pharmaceuticals Inc
Is there a genetic component of this disease? APFED's Webinar Series Presents… Answers from Experts Is there a genetic component of this disease? (1) Continue reading →
San Francisco, CA (PRWEB) April 02, 2014 CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on informing clinical decision-making in molecular medicine, and The Jackson Laboratory (JAX), an independent, nonprofit biomedical research institution with a staff of over 1,500 employees, today announced a multi-year agreement to access CollabRx technology and content resources in support of the clinical interpretation of genetic sequencing-based tests provided by JAX
Enabled Reduced Analysis Time Per Case, Improved Ability to Track & Query Identified Variants BOSTON and LEUVEN, Belgium – Cartagenia, the world leader in software-based workflow support for genetic variant assessment, lab reporting, and integration of diagnostic knowledge-bases, today announced that the Human Genetics Laboratory, part of the Munroe-Meyer Institute for Genetics and Rehabilitation (MMI) at the University of Nebraska Medical Center (UNMC), has selected the Cartagenia Bench platform genetics diagnostics solution for use at its healthcare laboratory. Cartagenia Bench is a cloud-based platform that allows genetics labs and clinicians to analyze, interpret, report, and share genomic variants in routine clinical diagnostics. Jennifer N
PUBLIC RELEASE DATE: 1-Apr-2014 Contact: Kathy Beal email@example.com 301-238-4582 American College of Medical Genetics Jun Shen, PhD was honored as the 2014 recipient of the ACMG Foundation/Signature Genomics from PerkinElmer, Inc. Travel Award at the American College of Medical Genetics and Genomics (ACMG) 2014 Annual Clinical Genetics Meeting in Nashville, TN. Dr
PUBLIC RELEASE DATE: 31-Mar-2014 Contact: Kimberley Wang firstname.lastname@example.org 65-660-11653 National University of Singapore A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and National University Cancer Institute Singapore (NCIS), and their collaborators from the Cedars-Sinai Medical Centre, UCLA School of Medicine, demonstrated that a number of novel genetic defects are able to induce oesophageal cancer. The research group, led by Professor H. Phillip Koeffler, Senior Principal Investigator at CSI Singapore and Deputy Director of NCIS, has conducted a successful comprehensive genomic study of oesophageal squamous carcinoma, a type of very aggressive cancer prevalent in Singapore and Southeast Asia
Heart valve defects are a common cause of death in newborns. Scientists at the University of Bonn and the caesar research center have discovered “Creld1″ is a key gene for the development of heart valves in mice. The researchers were able to show that a similar Creld1 gene found in humans functions via the same signaling pathway as in the mouse.